Biomaterials specialized company

ACE BIOPHARM

We have the solution you need

Report

Standard Balance Sheet (Dec. 2022)

(Unit: million won)

Current assets 46,173
Non-current assets 31,760
Total assets 77,933
Current liabilities 42,649
Non-current liabilities 16,204
Total liabilities 58,854
Capital 500
Retained earnings 18,135
Total equity 19,079

Standard Income Statement

 

[06784] 41, Dongsan-ro 8-gil, Seocho-gu, Seoul, Republic of Korea
CEO : Min-Byoung Gyu /  TEL : +82-2-579-1056  /  FAX : +82-2-6008-3356  /  E-mail : ace@acebiopharm.com

Copyright © 2010 ABP company. All Rights Reserved.